Max has worked for over 20 years in global, regional, and country health economics and outcomes research and market access roles in the pharmaceutical industry and consulting. 

​

He has worked on 200+ health technology appraisals (HTAs) across a wide range of disease areas including common, orphan, and ultra-orphan conditions, as well as on numerous HTA scientific advice projects, countless payer interactions. Max has also worked on multiple Business Development ( in-licensing and out-licensing ) projects. 

 

Max has a vast network of clinicians, payers, HTA experts, covering all aspects of market access, as well as regulatory and commercial experts.